Urinary Catheters Market By Product Type (Indwelling Catheters, Intermittent Catheters, and External Catheters), By Type (Coated Catheters and Uncoated Catheters), By Application (Urological Surgery, Post-surgical Recovery, Neurogenic Bladder, and Others), By Material (Latex Catheters, Silicone Catheters, Hydrophilic Catheters, and Other materials), and By End-user (Hospitals, Dialysis Centers, Long-term Care Facilities and Ambulatory Surgical Centers), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Urinary Catheters market accounted for USD 6.15 Billion in 2024 and is expected to reach USD 11.32 Billion by 2035, growing at a CAGR of around 5.7% between 2025 and 2035. The urinary catheter market manufactures catheters placed within the patient's body to drain urine from the bladder if the patient is physically unable to do so. The catheter is either indwelling (placed in for a long time) or intermittent (used when necessary). Among the driving forces behind the market include increased cases of urinary conditions, an aging population, and awareness in terms of Catheter-Associated Urinary Tract infections (CAUTIs). Innovations in catheter material and design aim to increase the comfort level of patients with low risks of infection. Key players in the market are manufacturers of both disposable as well as reusable catheters and all the related products, especially accessories.

Report Scope:

Market Dynamics

Rising Incidence of Urinary Incontinence and Prostate Surgeries Fuel Demand for Catheters

The increased prevalence of urinary incontinence and growing surgical cases of the prostate constitute major drivers for the urinary catheters market. The Urology Care Foundation estimates that over 33 million Americans have symptoms of an overactive bladder, leading to a significant cause of urinary incontinence. This condition affects majorly the elderly more significantly females and incidence is bound to rise with population aging. With the increasing demographics of aging populations, urinary incontinence has become an increasingly prevalent disease among elderly patients. It therefore stands to reason that increased pressure will be placed upon management solutions when the disease continues to spread.

Another indicator that points to increasing catheter use is prostate surgery. The rising incidence of prostate cancer and benign prostatic hyperplasia has accounted for a rise in the performance of prostate surgeries, of which many patients require catheter use in the post-surgical recovery phase. Along with these factors, improved awareness and acceptance of urinary health problems create more patients who seek medical assistance. Providers of health care become more inclined toward improving the patient outcomes; hence the catheter of high quality in demand increases, which will provide opportunities to innovate products and expand in the market.

Technological Innovations Enhance Comfort and Safety in Catheter Use

There is a strong impetus for growth in the market of urinary catheters through technological advancements in the materials and designs of catheters to enhance comfort for patients and minimize infection risks. Hydrophilic coatings and antimicrobial properties added to catheters reduce friction and activities of bacteria, ensuring proper comfort of the patients. For instance, with the adoption of silicone and high-end latex materials, catheters are developed softer and more flexible, causing minimal irritation along the urethra. In addition, there exist intelligent catheters with sensors that can monitor urine flow with early signs of infection.

The results become available in real-time to healthcare professionals. These innovations improve safety and effectiveness while fostering greater patient-friendly compliance. The growing focus by manufacturers on user-centered designs concerning catheter design is also propelling self-catheterization that supports the management of urinary health autonomy in patients. Generally, these technologies are important for the betterment of clinical results and increase market possibilities.

High Costs of Advanced Catheters Limit Accessibility for Healthcare Facilities

The high costs associated with advanced catheters pose a significant restraint in the urinary catheters market. Innovative catheters equipped with features, such as antimicrobial coatings and smart technology, offer superior benefits to patients; however, premium prices may push the budgets in resource-constrained areas such as smaller hospitals and clinics. These catheters might be more costly; hence, to cut down on costs, most facilities may settle for the cheaper, old-style catheters. This has the potential to hinder care to such patients and may even increase the risks of complications, such as infections.

There might also be insurance services for advanced options that are not readily available, which continues to add more complexities in trying to reach out to some patients who may require some advanced options. This financial constraint may limit the uptake of the latest solutions, hence retarding overall market growth and offering limited opportunities for manufacturers to cut corners with innovation. The factor cost is a very important area that requires working to increase accessibility through advanced catheter technologies.

The development of Antimicrobial Catheters Offers a Key Opportunity to Reduce Infection Risks

The development of catheters with antimicrobial properties presents a significant opportunity in the urinary catheters market. A study by the CDC showed that catheter-associated urinary tract infections rank among the top hospital-acquired infections. Today, CAUTIs account for about 30% of infections reported by hospitals. The inclusion of antimicrobial agents in catheter materials decreases the risk of infection so that the catheter users enjoy better safety and comfort.

This innovation addresses a key need in health care because infection prevention is critical to the concern of patients and providers; hospitals and other healthcare institutions further increasingly demand products representing best practices regarding infection prevention. Because of calls to the regulatory bodies on the need to curtail CAUTIs, there will be a trend of having competitive growth in the market and better improvement in the patients' conditions.

Integration of Smart Sensors in Catheters Presents Major Opportunity for Enhanced Patient Monitoring

A transformative opportunity in the urinary catheter market is in the development of catheters integrated with sensors for real-time monitoring. Such intelligent catheters could monitor vital metrics like urine output and even detect early signs of infections, thus ensuring timely intervention. Advanced catheters capable of receiving real-time data would greatly improve patient management by reducing the risk of complications and hospital readmissions by a great degree.

Integration of telemetry would facilitate better decision-making and personalized care in order to improve patient outcomes. Because the healthcare industry focuses increasingly on digital health solutions, demand for innovative catheter monitoring design is likely to grow, offering vast market opportunities for manufacturers of these products.

Industry Experts Opinion

"We are excited to expand our percutaneous drainage portfolio of products with the ACCEL All-Purpose and Biliary Drainage Catheters, now offering a full-system drainage solution to our customers and bringing value to their drainage procedures,"

• Dave Mittl, Vice President of BIS

“Our goal--and the inspiration behind the FLUME catheter--is to transform the lives of the 100 million patients worldwide who rely on indwelling urinary catheters. We expect to gain valuable insights from this study.”

• Dr. John Havard, Chairman and Chief Medical Officer, TFCC.

Segment Analysis

Based on the product type, the Urinary Catheters market has been classified into indwelling catheters, intermittent catheters and external catheters. The most widely used product type in the urinary catheters market includes indwelling catheters, which are hollow tubes inserted into the bladder for an extended period. Indwelling catheters are used widely in both hospitals and home care settings by patients who continuously drain due to conditions such as urinary retention or after surgery.

Based on the product type, the Urinary Catheters market has been classified into coated catheters and uncoated catheters. Coated catheters are usually the most prevailing due to their improved features, enhancing comfort for patients and reducing the risk of infection. Hydrophilic or antimicrobial coatings are typical on coated catheters, which help in reducing friction and inhibiting bacterial growth; such properties are favored by healthcare providers.

Regional Analysis

North America urinary catheters market is among the biggest and most advanced in the world with a high sum of healthcare spending, well-developed healthcare infrastructure, and an increased prevalence of urinary disorders. The demand is significantly boosted by an aging population in the region since the prevalence of catheterization is a common requirement to meet in the case of conditions such as urinary incontinence and prostate surgery. Moreover, more awareness about catheter-associated urinary tract infections urged concerns for the more advanced technology of the catheter such as coated and smart catheters that could improve patient safety and comfort.

Urinary Catheters market is growing at a fast pace in the Asia Pacific region attributed to increased investments in the healthcare sector, population awareness towards urinal health disorders, and the increasing geriatric population. Countries like China and India are witnessing an upsurge in prevalence of urinary disorders due to lifestyle changes and changes in demographics. This would require catheterization solutions among the population. The market is further driven by better health care infrastructure and access to advanced medical technology.

Competitive Landscape

The urinary catheter market has intense competition from a large number of major companies such as Boston Scientific Corporation, B. Braun Melsungen AG, Medtronic, and Coloplast A/S. They mainly aim at developing new products with innovative ideas for betterment in patient outcomes and risk reduction from infection. Examples include recent hydrophilic-coated catheters by B. Braun that also enhance comfort for the patients during use. Further, the company has invested in smart catheter technologies that carry sensors for the real-time monitoring of urine output. Companies are expanding geographically to undertake strategic alliances and acquisitions, thereby retaining a dynamic and competitive environment.

Urinary Catheters Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In June 2024, The B. Braun Group of Companies' B. Braun Interventional Systems Inc. (BIS) announced today the introduction of their new ACCEL® All-Purpose and Biliary Drainage Catheters with TrueGlide® Hydrophilic Coating for percutaneous drainage.
• In April 2023, a better Foley indwelling urinary catheter substitute is being developed by The Flume Catheter firm Ltd. (TFCC), a medical device firm. , the company announced the start of a research to collect firsthand information on patient experiences with the new FLUME catheter.

Report Coverage:

By Product Type

• Indwelling Catheters
• Intermittent Catheters
• External Catheters

By Type

• Coated Catheters
• Uncoated Catheters

By Application

• Urological Surgery
• Post-surgical Recovery
• Neurogenic Bladder
• Others

By Material

• Latex Catheters
• Silicone Catheters
• Hydrophilic Catheters
• Other materials

By End-user

• Hospitals
• Dialysis Centers
• Long-term Care Facilities
• Ambulatory Surgical Centers

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Boston Scientific Corporation
• Medtronic plc
• Bard Medical
• Coloplast A/S
• Hollister Incorporated
• Teleflex Incorporated
• B. Braun Melsungen AG
• Cook Medical
• C.R. Bard, Inc.
• ConvaTec Group PLC
• Smiths Medical
• Medi-Flex, Inc.
• Amsino International, Inc.
• Urocare Products, Inc.
• Parker Hannifin Corporation

Frequently Asked Questions (FAQs)